RIGI and melanoma: Intratumoral activation of the cytoplasmic double-stranded RNA (dsRNA) sensor retinoic acid-inducible gene I (RIG-I) alone elicits a potent anti-tumor immune response resulting in melanoma control through the concurrent induction of a pro-inflammatory immune response and programmed cell death of tumor cells.20